ASCO Genitourinary Cancers Symposium 2027
The ASCO Genitourinary Cancers Symposium is a three-day meeting on prostate, bladder, kidney and other GU cancers, held each February in San Francisco. ASCO runs it with ASTRO and the Society of Urologic Oncology.
Thursday to Saturday · 3 days
American Society of Clinical Oncology
Organizer
Published by the organizer
Every year
How often it's held
Checked November 14, 2026
Reported attendance
5,850
total registrations · 2026
Reported exhibitors
Not published
About ASCO Genitourinary Cancers Symposium 2027
The ASCO Genitourinary Cancers Symposium is a three-day scientific meeting on prostate, bladder, kidney and other GU cancers. The American Society of Clinical Oncology runs it with ASTRO and the Society of Urologic Oncology as cosponsors. The 2027 symposium runs February 11 to 13 at Moscone West in San Francisco, in person and online. ASCO counted 5,850 registrations at the 2026 meeting from 57 countries.
5,000
Professional attendees
57
Countries represented
800
Online-only professionals
620
Exhibitor registrations
28 to 1
Attendee to exhibitor ratio
What happens at the ASCO Genitourinary Cancers Symposium
The symposium mixes oral abstracts, poster sessions, tumor boards and education sessions across GU cancers. ASCO's 2027 program overview sets the theme "Pioneering Breakthroughs, Optimizing Patient Outcomes."
Each day has its own focus. Thursday covers prostate cancer, Friday covers urothelial carcinoma, and Saturday covers kidney, adrenal, penile, urethral and testicular cancers.
Every day opens with an oral abstract session and closes the science with a rapid oral abstract session. Multidisciplinary tumor boards bring urologic, medical and radiation oncologists together with pathologists and radiologists.
Poster and Trials in Progress sessions run over lunch and into evening wine and cheese receptions. The program also lists poster walks, a trainee and early career luncheon and a Women in Genitourinary Cancers luncheon.
ASCO's own ASCO Daily News covers the meeting. Independent coverage of 2026 in CancerNetwork highlighted bladder and kidney cancer results.
ASCO's flagship meeting has its own page on this site, the ASCO Annual Meeting 2027.
What's new for ASCO GU 2027
The 2027 dates fall about two weeks earlier in the calendar than the 2026 edition. The exhibit enhancements list two new items, print-your-badge iPads and a registration confirmation bundle.
Abstract titles come out on January 5, 2027, and full abstracts on February 8, 2027. Both dates are on the symposium FAQ.
Who attends the ASCO Genitourinary Cancers Symposium
Clinicians and researchers in GU oncology make up most of the audience, with a large industry share. ASCO's 2026 registration numbers show 5,850 registrations in total.
- Medical Oncologist18%
- Pharmaceutical Marketing and Sales13%
- Clinical Oncologist13%
- Urologist8%
- Researcher8%
- Medical Science Liaison4%
- Oncology Fellow/Resident4%
- Consultant3%
- Pharmacist3%
- Radiation Oncologist2%
Share of the 5,000 professional registrants who answered (96% responded). Top 10 of 21 roles shown.2026 · asco.org ↗
- United States3,067
- Canada233
- Brazil160
- Germany160
- Japan145
2026 · asco.org ↗
- In-Person + Online Professionals4,200
- Online-Only Professionals800
- Exhibitors620
- Media and Others230
2026 · asco.org ↗
That total held 5,000 professional attendees, 620 exhibitor registrations and 230 media and others. Of the professionals, 4,200 registered for in-person plus online access and 800 for online only.
Medical oncologists were the largest professional group at 18%. Pharmaceutical marketing and sales staff and clinical oncologists followed at 13% each, then urologists and researchers at 8% each.
The United States sent 3,067 attendees in 2026. Canada sent 233, Brazil and Germany 160 each, and Japan 145.
ASCO's exhibitor site gives an attendee to exhibitor ratio of 28 to 1.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| 2026 | 5,850total registrations, incl. 5,000 professionals (800 online only), 620 exhibitor registrations and 230 media and othersASCO's 2026 registration numbersasco.org ↗ |
Companies exhibiting and sponsoring at the ASCO GU Cancers Symposium 2027
Pharma, biotech and diagnostics companies dominate the 2027 exhibitor directory. The list below comes from that directory and ASCO's featured exhibitors page as of 14 November 2026.
Sponsors (6)Astellas, AstraZeneca, Bristol Myers Squibb and 3 more
- AstellasSponsorship Donor (Gold) through Conquer Cancer, listed on the symposium site, edition not stated
- AstraZenecaSponsorship Donor (Gold) through Conquer Cancer, listed on the symposium site, edition not stated
- Bristol Myers SquibbSponsorship Donor (Gold) through Conquer Cancer, listed on the symposium site, edition not stated
- EisaiSponsorship Donor (Gold) through Conquer Cancer, listed on the symposium site, edition not stated
- NovartisSponsorship Donor (Gold) through Conquer Cancer, listed on the symposium site, edition not stated
- LantheusGenitourinary Cancers Symposium Donor (Innovator), edition not stated
Partners (2)Society of Urologic Oncology, American Society for Radiation Oncology (ASTRO)
Exhibitors (29)AbbVie, American Society for Radiation Oncology (ASTRO), Amgen Inc. and 26 more
- AbbVie · 2027Booth 217. Featured exhibitor
- American Society for Radiation Oncology (ASTRO) · 2027Booth 300. Featured exhibitor
- Amgen Inc. · 2027Booth 109
- Artera · 2027Booth 306
- Astellas Pharma · 2027Booths 301 and 115. Featured exhibitor
- AstraZeneca · 2027Booths 105 and 304
- AVEO Oncology, an LG Chem company · 2027Booth 316. Featured exhibitor
- Bayer · 2027Meeting rooms MR41 and MR42, plus Bayer Medical Affairs at booths 229, 231 and 326
- BillionToOne · 2027Booth 328
- BioNTech SE · 2027Booth 321. Featured exhibitor
- Blue Earth Diagnostics, Inc. · 2027Booth 125
- Boehringer Ingelheim Pharmaceuticals, Inc. · 2027Booth 225 and meeting room MR48
- Bristol Myers Squibb · 2027Booths 215 and 119 and meeting rooms MR29 to MR32
- Canadian Urological Association · 2027Booth 310
- Candel Therapeutics · 2027Booth 324
- Caris Life Sciences · 2027Booth 222
- City of Hope · 2027Booth 123
- Clarity Pharmaceuticals · 2027Booth 311
- Curium · 2027Booth 209
- Daiichi Sankyo · 2027Booths 129 and 228 and meeting rooms MR45 and MR46
- Foundation Medicine, Inc. · 2027Booth 307. Featured exhibitor
- Handa Pharmaceuticals · 2027Booth 327. Featured exhibitor
- ImmunityBio, Inc. · 2027Booth 318. Featured exhibitor
- Natera, Inc. · 2027Booth 315. Featured exhibitor
- Pfizer Oncology · 2027Booths 208 and 214. Featured exhibitor
- Quest Diagnostics · 2027Booth 319. Featured exhibitor
- Telix Pharmaceuticals (US) Inc. · 2027Booth 101. Featured exhibitor
- Tempus · 2027Booth 111. Featured exhibitor
- Tyra Biosciences, Inc. · 2027Booth 308. Featured exhibitor
Large drugmakers include AbbVie, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Daiichi Sankyo and Pfizer Oncology. Diagnostics and data companies include Caris Life Sciences, Foundation Medicine, Natera, Quest Diagnostics and Tempus.
Radiopharmaceutical companies such as Curium, Clarity Pharmaceuticals, Blue Earth Diagnostics and Telix also have booths. Professional groups exhibiting include ASTRO and the Canadian Urological Association.
Companies also present data without being listed as exhibitors. Merck said it would present bladder and kidney cancer data at the 2026 symposium.
Exhibitors at the ASCO Genitourinary Cancers Symposium
Exhibits are tabletop displays in the room that also holds posters and meals. ASCO's exhibit page prices a table at $12,500.
The package includes a draped counter-high table, five full registrations and a reference list of attendees. Nonprofits get three registrations. It also adds directory listings and priority points toward the 2028 ASCO Annual Meeting.
Exhibitors can rent private meeting rooms in Moscone West at Standard, Premium and Deluxe levels. Industry Expert Theater sessions cost $45,000 for up to 50 in-person attendees.
Branding add-ons sit on the enhancements page, and several were already sold in November 2026. A featured listing in the 2027 exhibitor directory costs $1,000.
Exhibits open only on February 11 and 12, 2027, per the exhibitor general information page. Booking runs through SPARGO, ASCO's exhibit contractor.
Exhibitors use the Capture! service from SPARGO for lead retrieval. This site compares lead retrieval apps in general.
Sponsors and partners at the ASCO Genitourinary Cancers Symposium
Industry support runs through Conquer Cancer, the ASCO Foundation, rather than a sponsor package. The symposium site lists Gold Sponsorship Donors Astellas, AstraZeneca, Bristol Myers Squibb, Eisai and Novartis.
Lantheus is listed as a Genitourinary Cancers Symposium Donor at the Innovator level. ASCO doesn't say which edition these listings cover.
The cosponsors page names ASCO, the American Society for Radiation Oncology and the Society of Urologic Oncology. ASTRO and SUO members get a registration discount.
Advertising, support and ancillary events are explained on the additional opportunities page. Our guide to event sponsorship software covers how organizers sell these packages.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
ASCO GU attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
ASCO publishes its exhibitor list but doesn't sell an attendee email list. The online exhibitor directory lists each company with booth numbers.
ASCO's registration page warns about attendee list scams. It says it doesn't sell or transfer attendee information to third parties for commercial purposes.
ASCO says it works with InFocus for mailing list sales and never sells email addresses. Exhibitors also get a reference list of attendees in their package.
The donor list appears at the foot of the symposium home page. For other ways to research an audience, see how to find who's attending an event and our event intelligence platforms roundup.
See who's attending ASCO Genitourinary Cancers Symposium
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at the ASCO GU Cancers Symposium 2027
ASCO has named four featured speakers for 2027 on the symposium home page. W. Kimryn Rathmell of The Ohio State University Comprehensive Cancer Center gives the keynote.
More speakers (3)Jose A. Karam, Alberto Bossi, Andrea B. Apolo
- Jose A. KaramChair, 2027 ASCO Genitourinary Cancers Symposium, The University of Texas MD Anderson Cancer Center2027
- Alberto BossiChair-Elect, 2027 ASCO Genitourinary Cancers Symposium, Amethyst Radiotherapy Group, France2027
- Andrea B. ApoloImmediate Past Chair, 2027 ASCO Genitourinary Cancers Symposium, National Cancer Institute, National Institutes of Health2027
Jose A. Karam of The University of Texas MD Anderson Cancer Center chairs the 2027 symposium. Alberto Bossi of Amethyst Radiotherapy Group in France is Chair-Elect.
Andrea B. Apolo of the National Cancer Institute is Immediate Past Chair. The full faculty for each session will appear in the ASCO Meetings App and online program.
Abstract first authors upload posters through ASCO's Speaker Center by January 25, 2027.
Dates, venue and getting there
The 2027 symposium runs February 11 to 13 at Moscone West, 800 Howard Street, San Francisco. ASCO's exhibitor information page gives the address and exhibit hours.
Exhibits open 7 a.m. to 6.45 p.m. on Thursday and 7 a.m. to 5.45 p.m. on Friday. Exhibitor move-in is the afternoon of Wednesday, February 10.
The venue's event listing for ASCO GU describes an earlier February 13 to 15 edition at the Moscone Center.
ASCO books hotels through SPARGO and asks attendees to reserve only through its website. The hotel deadline is December 16, 2026.
Tickets and registration for ASCO GU 2027
Registration is open to the cancer care community, with lower rates for ASCO members. The 2027 registration page lists early in-person fees from $975 for member physicians and $1,495 for nonmembers.
Industry and nonmedical attendees pay $1,835 in person by December 16, 2026, rising to $2,060 from January 23, 2027. Online-only industry passes start at $1,465.
Trainees, affiliated health professionals and patient advocates get reduced rates. Patient advocates can join online for free.
The in-person fee covers sessions, posters, exhibits, on-demand content, breakfasts, boxed lunches and poster receptions. Prices were checked in November 2026.
You can switch from in-person to online and get the difference back until February 7, 2027. Onsite registration closes at 3 p.m. Pacific on February 13.
History of the ASCO Genitourinary Cancers Symposium
The symposium began in 2005 as a prostate cancer meeting. An ASCO Daily News podcast marking its 20th anniversary says 1,035 people came to the first meeting in San Francisco.
The founding cosponsors were ASCO, ASTRO, SUO and the Prostate Cancer Foundation. The meeting moved between San Francisco and Florida before settling in San Francisco.
It later grew to cover all GU cancers. The 2026 edition ran February 26 to 28 in San Francisco and online.
Resources for exhibitors, sponsors and attendees
These official ASCO and SPARGO pages cover registration, exhibiting and the program.
- Symposium home pageFor dates, speakers and donors.
- Registration detailsFor fees, deadlines and the scam warning.
- Program overviewFor the day-by-day schedule.
- Previous meeting demographicsFor 2026 attendance data.
- Exhibit at ASCO GUFor table prices and the application.
- 2027 exhibitor directoryFor who's exhibiting.
- Exhibit floor planFor table locations.
- Exhibitor contacts and official vendorsFor sales, lead retrieval and services.
- Media resourcesFor press credentials and embargo rules.